Mepro’s prowess in fulfilling unmet customer needs stems from our 4 state-of-the-art manufacturing facilities spread across India. Operational excellence, coupled with dedication to quality and regulatory compliance, have enabled us to deliver superior quality products worldwide.
Our manufacturing philosophy is simple, yet effective. We aim to eliminate operational inefficiencies, facilitate teamwork and encourage lean manufacturing using the principles of Six Sigma. We conduct frequent self-inspection at our facilities that are periodically audited by various regulatory agencies as well.
Mepro has been continuously investing in new technology, automation, and IT-driven systems which reduce human intervention and ensure complete confidentiality. We believe that quality should not only be embedded into the product, but also has to be built into the culture of the company, its people and its systems through continuous training and knowledge sharing.
Unit I
Located at Surendranagar, Gujarat, it started operations in 1982. This is the first plant of Mepro that manufactures tablets, capsules and dry powder cephalosporin Injectables.
Address:
1003, GIDC, Wadhwan City,
Surendranagar,
Gujarat – 363 035, India.
Approvals:
State GMP, MOH of DR Congo,
DPM Ivory Coast, Republic of Yemen
Unit II
This plant commenced its operations in 2004, and manufactures tablets, capsules, creams and ointments. Our technologically advanced R&D facility is also located in this premises.
Address:
Q-Road, Phase IV, GIDC, Wadhwan City,
Surendranagar,
Gujarat – 363 035, India.
Approvals:
UK MHRA, EU GMP, TGA Australia, PIC/s, WHO GMP, UNICEF, Kazakhstan, MOH of DR Congo, DPM Ivory Coast, NAFDAC Nigeria, P&PB Kenya, Republic of Yemen, MOH Sudan
Unit III
Our newest, most modern facility is based out of Vadodra, Gujarat. This plant is engaged in the manufacturing of tablets, capsules, and sachets in the non-sterile space and ampoules, vials, and lyophilised vials in the sterile injectables space.
Address:
Plot No. 141/2 & 227, Haripura, Ta.-Savli, Jarod,
Samlaya Road,
Vadodra – 391520, Gujarat, India.
Approvals:
EU GMP, WHO GMP, MOH of DR Congo
MeproMax Life Sciences Pvt. Ltd.
Catering to the Indian pharmaceutical market, this plant was built in 2006 and manufactures tablets, capsules, creams, and ointments in the non-sterile segment and dry powder carbapenems in the injectables segment.
Address:
16, Pharma City, Selaqui,
Dehradun,
Uttarakhand – 248 011. India.
Approvals:
State GMP, WHO GMP, MOH of DR Congo, Republic of Yemen, Kazakhstan